CD34 and neoplasm: Considering the association observed between CD117+ cell subsets and tumor response, we investigated whether baseline blood concentrations of CD117-expressing CD34+/CD45dim cells and the percentage of annexin V-negative cells within this cell subset were associated with survival in patients with mCRC (n = 40).